Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast.
de Boer M, Hauptmann M, Hijmering NJ, van Noesel CJM, Rakhorst HA, Meijers-Heijboer HEJ, de Boer JP, van der Hulst RRWJ, de Jong D, van Leeuwen FE. de Boer M, et al. Among authors: hijmering nj. Blood. 2020 Sep 10;136(11):1368-1372. doi: 10.1182/blood.2019004498. Blood. 2020. PMID: 32452517 Free article. No abstract available.
Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.
de Boer M, van der Sluis WB, de Boer JP, Overbeek LIH, van Leeuwen FE, Rakhorst HA, van der Hulst RRWJ, Hijmering NJ, Bouman MB, de Jong D. de Boer M, et al. Among authors: hijmering nj. Aesthet Surg J. 2017 Sep 1;37(8):NP83-NP87. doi: 10.1093/asj/sjx098. Aesthet Surg J. 2017. PMID: 29036941
Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.
de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D. de Boer M, et al. Among authors: hijmering nj. JAMA Oncol. 2018 Mar 1;4(3):335-341. doi: 10.1001/jamaoncol.2017.4510. JAMA Oncol. 2018. PMID: 29302687 Free PMC article.
Benign and malignant tumors in Rubinstein-Taybi syndrome.
Boot MV, van Belzen MJ, Overbeek LI, Hijmering N, Mendeville M, Waisfisz Q, Wesseling P, Hennekam RC, de Jong D. Boot MV, et al. Am J Med Genet A. 2018 Mar;176(3):597-608. doi: 10.1002/ajmg.a.38603. Epub 2018 Jan 23. Am J Med Genet A. 2018. PMID: 29359884 Free PMC article.
Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs.
de Boer M, van Middelkoop M, Hauptmann M, van der Bijl N, Bosmans JAW, Hendriks-Brouwer N, Schop SJ, de Boer JP, Hijmering NJ, Overbeek LIH, Lobbes MBI, Klazen CAH, de Jong D, Rakhorst HA, van der Hulst RRWJ, van Leeuwen FE. de Boer M, et al. Among authors: hijmering nj. Aesthet Surg J. 2020 Jan 29;40(2):156-164. doi: 10.1093/asj/sjz136. Aesthet Surg J. 2020. PMID: 31242279 Free PMC article.
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.
Lugtenburg PJ, Zijlstra JM, Doorduijn JK, Böhmer LH, Hoogendoorn M, Berenschot HW, Beeker A, van der Burg-de Graauw NC, Schouten HC, Bilgin YM, Kersten MJ, Koene HR, Herbers AHE, de Jong D, Hijmering N, Lam KH, Chiţu D, Brouwer RE, van Imhoff GW; Dutch HOVON group. Lugtenburg PJ, et al. Br J Haematol. 2019 Nov;187(3):347-355. doi: 10.1111/bjh.16087. Epub 2019 Jul 10. Br J Haematol. 2019. PMID: 31290569 Free article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 31857360
[No title available]
[No authors listed] [No authors listed] PMID: 32898861
21 results